Gris JC, Lissalde-Lavigne G, Quére I, Marés P. Monitoring the effects and managing the side effects of anticoagulation during pregnancy.
Obstet Gynecol Clin North Am 2006;
33:397-411. [PMID:
16962917 DOI:
10.1016/j.ogc.2006.05.004]
[Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
LMWHs are the major anticoagulant/antithrombotic treatment given to pregnant women to prevent and treat venous thromboembolism despite the absence of specific clinical trials. An emerging indication, the prevention of adverse pregnancy outcomes, is under investigation. During pregnancy, LMWHs seem to be safe and efficient. Some uncertainties remain about the management of rare potential side effects, particularly in the event of heparin intolerance and with cross-reactivity to danaparoid sodium.
Collapse